Janssen Vaccines & Prevention competitive analysis

Explore patent oppositions filed by Janssen Vaccines & Prevention against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Aug 27, 2026
Patent NumberTitleApplicantOpposition Date
Rsv F Protein Compositions And Methods For Making SameGLAXOSMITHKLINE BIOLOGICALS SAJan 19, 2023
Novel Prime-Boosting Regimens Involving Immunogenic Polypeptides Encoded By PolynucleotidesGLAXOSMITHKLINE BIOLOGICALS SAMay 24, 2022
Delivery Of Rna To Different Cell TypesGLAXOSMITHKLINE BIOLOGICALS SAMay 27, 2020
Recombinant Rsv AntigensGLAXOSMITHKLINE BIOLOGICALS SAOct 23, 2019
Immunisation Of Large Mammals With Low Doses Of RnaGLAXOSMITHKLINE BIOLOGICALS SAMar 7, 2017
Improved Viral Purification MethodsONCOLYTICS BIOTECHSep 14, 2016

Latest PTAB cases involving Janssen Vaccines & Prevention

Discover the latest PTAB cases involving Janssen Vaccines & Prevention, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Janssen Vaccines & Prevention with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Aug 27, 2026
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
JANSSEN VACCINES & PREVENTION6 - - -
GLAXOSMITHKLINE BIOLOGICALS SA2910429
ID BIOMEDICAL OF QUEBEC - 2 - -
NOVARTIS12564 - 21